Chronic Fatigue Syndrome Trial, Recruiting (NCT05638724)

Chronic Fatigue Syndrome Trial, Recruiting NCT05638724 Sponsor: Technical University of Munich Condition: Chronic Fatigue Syndrome

Printed from Voxsanity (voxsanity.com.au) — NCT05638724 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Chronic Fatigue Syndrome

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are willing and able to give written consent to take part, or a legal guardian can do this on your behalf.
You have had a confirmed COVID-19 vaccination and/or have had a confirmed or likely COVID-19 infection (shown by a positive PCR test, rapid antigen test, a typical chest scan result, close contact with a known case, or blood tests showing antibodies to the virus).
You have been given a diagnosis of a suspected post-COVID-19 condition (sometimes called "Long COVID") or a suspected adverse reaction following a COVID-19 vaccine (confirm with trial site).

Who may not be able to join:

Any new medical information comes to light that suggests you do not actually have Long COVID or a post-vaccine condition.
Your symptoms can be fully explained by a different illness or health condition.
You are currently pregnant.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Uta Behrends, Prof. Dr. med., MRI Chronic Fatigue Center for Young People (MCFC), Children's Hospital, Technical University of Munich & Munich Municipal Hospital

Phone: +4989 3068 2632

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05638724

Sponsor: Technical University of Munich

Phase: Not Applicable

Status: Recruiting

Condition: Chronic Fatigue Syndrome

Trial contact: +4989 3068 2632

More information: https://clinicaltrials.gov/study/NCT05638724

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are willing and able to give written consent to take part, or a legal guardian can do this on your behalf.
You have had a confirmed COVID-19 vaccination and/or have had a confirmed or likely COVID-19 infection (shown by a positive PCR test, rapid antigen test, a typical chest scan result, close contact with a known case, or blood tests showing antibodies to the virus).
You have been given a diagnosis of a suspected post-COVID-19 condition (sometimes called "Long COVID") or a suspected adverse reaction following a COVID-19 vaccine (confirm with trial site).

Who may not be able to join:

Any new medical information comes to light that suggests you do not actually have Long COVID or a post-vaccine condition.
Your symptoms can be fully explained by a different illness or health condition.
You are currently pregnant.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Technical University of Munich

Registry

ClinicalTrials.gov

Start date

20 July 2022

Est. completion

20 July 2027

Where this trial is recruiting

🇩🇪 Germany

Primary endpoints

Phenotyping of Post-COVID condition: Medical History; Phenotyping of Post-COVID condition: Physical Examination; Phenotyping of Post-COVID condition: Laboratory Parameters; Phenotyping of Post-COVID condition: Functional Tests

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov